The first endoscopic intraluminal gastroplasty in the treatment of a patient with morbid obesity

Introduction. Endoscopic gastroplasty is a minimally invasive and, importantly, reversible method for treating patients with morbid obesity, performed transorally. The restrictive effect of this intervention is achieved by reducing the volume of the stomach, similar to laparoscopic sleeve resection, through the endoscopic placement of numerous endoluminal sutures that pass through all the walls of the stomach - starting from the antral part and extending to the upper third of the body of the stomach. The Apollo Overstitch™ system is used for this procedure. It is worth noting that this device was registered in the Russian Federation in 2024. Clinical observation. A 34-year-old female patient underwent endoscopic treatment at the A.V. Vishnevsky National Medical Research Center of Surgery for grade 3 morbid obesity. Results. In our clinical observation, we achieved convincing results in the treatment of a patient with grade 3 morbid obesity. The endoscopic approach used for performing gastroplasty not only allowed for a complete gastric restriction similar to laparoscopic sleeve gastrectomy but also minimized postoperative complications. Conclusion. Endoscopic gastroplasty in the treatment of patients with morbid obesity is an optimal, modern technique and a preferred alternative to traditional surgical interventions. The undeniable advantages of this method include a stable functional outcome, a low level of complications, and a short postoperative period, allowing for a rapid return of patients to their usual lifestyle without the need for prolonged rehabilitation.